Table 3. Incidence of late recurrence by site, categorized by patient serum 25(OH)D status after 5-year adjuvant endocrine therapy.
Site of late recurrence | Serum 25(OH)D status after 5-yr adjuvant endocrine therapy | ||
---|---|---|---|
Deficient | Sufficient | Total | |
Local | 2 | 1 | 3 |
Regional LN | 23 | 1 | 24 |
Bone | 25 | 7 | 32 |
Visceral | 26 | 7 | 33 |
Total | 76 | 16 | 92 |
25(OH)D = 25-hydroxyvitamin D; LN = lymph node.